This clinical trial aims to evaluate the effectiveness and safety of a new medication for managing diabetes. Participants will be monitored over a period to assess improvements in blood sugar levels and overall health outcomes.
- Who Can Participate: Individuals aged 18-65 with a diagnosis of type 2 diabetes
- Study Details: The trial will last for 12 months, during which participants will receive the study medication and attend regular health check-ups
- Study Timelines and Visits: The study will begin in January 2024 and conclude in December 2024.Participants will need to attend 8 visits over the course of the study
How understandable was the trial content above?
Hard to understand
Easy to understand